1. Home
  2. FUBO vs MYGN Comparison

FUBO vs MYGN Comparison

Compare FUBO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

N/A

Current Price

$1.18

Market Cap

409.1M

Sector

Industrials

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$4.85

Market Cap

481.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FUBO
MYGN
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
409.1M
481.6M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
FUBO
MYGN
Price
$1.18
$4.85
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$3.98
$8.06
AVG Volume (30 Days)
14.9M
1.3M
Earning Date
04-29-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
48.08
N/A
EPS
N/A
N/A
Revenue
$4,271,000.00
$771,400,000.00
Revenue This Year
$24.29
$7.19
Revenue Next Year
$26.51
$5.64
P/E Ratio
N/A
N/A
Revenue Growth
10317.07
2.33
52 Week Low
$1.11
$3.76
52 Week High
$4.72
$11.44

Technical Indicators

Market Signals
Indicator
FUBO
MYGN
Relative Strength Index (RSI) 22.20 43.74
Support Level N/A $3.93
Resistance Level $2.79 $5.67
Average True Range (ATR) 0.07 0.39
MACD 0.04 0.11
Stochastic Oscillator 26.07 44.41

Price Performance

Historical Comparison
FUBO
MYGN

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: